NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.
Publication
, Journal Article
Horwitz, SM; Ansell, SM; Ai, WZ; Barnes, J; Barta, SK; Choi, M; Clemens, MW; Dogan, A; Greer, JP; Halwani, A; Haverkos, BM; Hoppe, RT; Oki, Y ...
Published in: J Natl Compr Canc Netw
February 2018
Natural killer (NK)/T-cell lymphomas are a rare and distinct subtype of non-Hodgkin's lymphomas. NK/T-cell lymphomas are predominantly extranodal and most of these are nasal type, often localized to the upper aerodigestive tract. Because extranodal NK/T-cell lymphomas (ENKL) are rare malignancies, randomized trials comparing different regimens have not been conducted to date and standard therapy has not yet been established for these patients. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with ENKL as outlined in the NCCN Guidelines for T-Cell Lymphomas.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
February 2018
Volume
16
Issue
2
Start / End Page
123 / 135
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Lymphoma, T-Cell
- Humans
- Disease Management
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Horwitz, S. M., Ansell, S. M., Ai, W. Z., Barnes, J., Barta, S. K., Choi, M., … Sundar, H. (2018). NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018. J Natl Compr Canc Netw, 16(2), 123–135. https://doi.org/10.6004/jnccn.2018.0007
Horwitz, Steven M., Stephen M. Ansell, Weiyun Z. Ai, Jeffrey Barnes, Stefan K. Barta, Michael Choi, Mark W. Clemens, et al. “NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.” J Natl Compr Canc Netw 16, no. 2 (February 2018): 123–35. https://doi.org/10.6004/jnccn.2018.0007.
Horwitz SM, Ansell SM, Ai WZ, Barnes J, Barta SK, Choi M, et al. NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018. J Natl Compr Canc Netw. 2018 Feb;16(2):123–35.
Horwitz, Steven M., et al. “NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.” J Natl Compr Canc Netw, vol. 16, no. 2, Feb. 2018, pp. 123–35. Pubmed, doi:10.6004/jnccn.2018.0007.
Horwitz SM, Ansell SM, Ai WZ, Barnes J, Barta SK, Choi M, Clemens MW, Dogan A, Greer JP, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Kim YH, Lunning MA, Mehta A, Mehta-Shah N, Oki Y, Olsen EA, Pro B, Rajguru SA, Shanbhag S, Shustov A, Sokol L, Torka P, Wilcox R, William B, Zain J, Dwyer MA, Sundar H. NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018. J Natl Compr Canc Netw. 2018 Feb;16(2):123–135.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
February 2018
Volume
16
Issue
2
Start / End Page
123 / 135
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Lymphoma, T-Cell
- Humans
- Disease Management
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis